Financhill
Back

EyePoint Pharmaceuticals Vs. Editas Medicine Industry Stock Comparison

Sell
50

EYPT
EyePoint Pharmaceuticals

Last Price:
8.65
Seasonality Move:
-4.78%
Sell
38

EDIT
Editas Medicine

Last Price:
3.39
Seasonality Move:
22%
Sell
50
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.63. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.38. The Score for EDIT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.63
    The current trend is relatively stagnant and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight buying pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 53.06 Buy
Chaikin Money Flow: 175844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.04 - 8.82) Buy
Bollinger Bands (100): (8.03 - 10.31) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: 457652 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.38 - 3.82) Sell
Bollinger Bands (100): (3.8 - 5.48) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.18 Buy
20-day SMA: 8.46 Buy
50-day SMA: 8.6 Buy
200-day SMA: 15.81 Sell
8-day EMA: 8.33 Buy
20-day EMA: 8.4 Buy
50-day EMA: 8.79 Sell
200-day EMA: 11.92 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.36 Buy
20-day SMA: 3.6 Sell
50-day SMA: 3.96 Sell
200-day SMA: 6.19 Sell
8-day EMA: 3.38 Buy
20-day EMA: 3.55 Sell
50-day EMA: 3.96 Sell
200-day EMA: 5.77 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):